CBD SAFETY PROFILE
Research has shown that unlike narcotics, CBD has no potential for addiction, and because CBD does not affect the area of the brain that controls breathing, lethal overdoses do not occur. Also, because THC-Free CBD contains NO CB1 activating psychoactive substance, urine drug screens are not required by your doctor if you are not taking other controlled substances.
During the Senate Drug Caucus, the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), shared testimony about the biology and the potential therapeutic effects of cannabidiol (CBD) and early preclinical findings that suggest that CBD may have therapeutic value as a treatment of substance use disorders, “CBD is a cannabinoid that doesn’t make people “high.” It may be useful in reducing pain and inflammation, controlling epileptic seizures, and possibly even treating mental illness and addictions.”
According to the National Cancer Institute, “Because cannabinoid receptors, unlike opioid receptors, are not located in the brainstem areas controlling respiration, lethal overdoses from cannabis and cannabinoids do not occur.”
Current Research suggests that CBD may be and alternative and innovative approach to pain management and narcotic addiction with a non-habit forming profile. As healthcare professionals, we understand the science and rationale behind how and why it works, but as the individuals at the bedside caring for people, we understand the need!
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
The statements made regarding GEN products have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented on our website and marketing materials are not meant as a substitute for or an alternative to information from your health care provider. Please consult your physician regarding potential interactions or other possible complications before using CBD.